<SUBMISSION>
<ACCESSION-NUMBER>0001181431-09-019286
<TYPE>3
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20090328
<FILING-DATE>20090406
<DATE-OF-FILING-DATE-CHANGE>20090406
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME>Novelly Michael
<CIK>0001460505
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE>3
<ACT>34
<FILE-NUMBER>001-32431
<FILM-NUMBER>09735636
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1>C/O DOLBY LABORATORIES, INC.
<STREET2>100 POTRERO AVENUE
<CITY>SAN FRANCISCO
<STATE>CA
<ZIP>94103
</MAIL-ADDRESS>
</REPORTING-OWNER>
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME>Dolby Laboratories, Inc.
<CIK>0001308547
<ASSIGNED-SIC>3663
<IRS-NUMBER>900199783
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>0930
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1>100 POTRERO AVENUE
<CITY>SAN FRANCISCO
<STATE>CA
<ZIP>94103
<PHONE>415 558 0200
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>100 POTRERO AVENUE
<CITY>SAN FRANCISCO
<STATE>CA
<ZIP>94103
</MAIL-ADDRESS>
</ISSUER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>rrd239074.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2009-03-28</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001308547</issuerCik>
        <issuerName>Dolby Laboratories, Inc.</issuerName>
        <issuerTradingSymbol>DLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001460505</rptOwnerCik>
            <rptOwnerName>Novelly Michael</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DOLBY LABORATORIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>100 POTRERO AVENUE</rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94103</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Interim CFO &amp; Vice President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Class A Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>7800</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Employee Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>46.06</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2018-05-15</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Class A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>20000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>32.18</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2019-02-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Class A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>15000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Shares held include an aggregate of 7,800 restricted stock units, 4,500 of which were granted on May 15, 2008 and 3,300 of which were granted on February 9, 2009, both of which were granted under the terms of the Issuer's 2005 Stock Plan and are subject to forfeiture until they vest.  Under the terms of the respective restricted stock unit grant agreements, 1/4 of the 4,500 units shall vest on each anniversary of May 15, 2008 and 1/4 of the 3,300 units shall vest on each anniversary of February 9, 2009.  Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.</footnote>
        <footnote id="F2">This option was granted for a total of 20,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on each anniversary of May 15, 2008, the vesting commencement date.</footnote>
        <footnote id="F3">This option was granted for a total of 15,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of February 9, 2009, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Alan G. Smith, Attorney-in-fact</signatureName>
        <signatureDate>2009-04-06</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.
<SEQUENCE>2
<FILENAME>rrd214399_242257.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<HTML>
<HEAD>
<TITLE>
rrd214399_242257.html
</TITLE>
</HEAD>
<BODY>
<PRE>
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of Dolby Laboratories, Inc. (the "Company"),
hereby constitutes and appoints Mark S. Anderson, Phyllis T. Solomon, Alan G. Smith and Wilson
Sonsini Goodrich & Rosati, P.C., and each of them, the undersigned's true and lawful attorney-in-
fact to:
1.	complete and execute Forms ID, 3,4 and 5 and other forms and all amendments thereto as
such attorney-in-fact shall in his or her discretion determine to be required or advisable
pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules
and regulations promulgated thereunder, or any successor laws and regulations, as a
consequence of the undersigned's ownership, acquisition or disposition of securities of
the Company; and
2.	do all acts necessary in order to file such forms with the Securities and Exchange
Commission, any securities exchange or national association, the Company and such
other person or agency as the attorney-in-fact shall deem appropriate.
The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or
cause to be done by virtue hereof.  The undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 (as amended).
This Power of Attorney shall remain in full force and effect until the undersigned is no longer
required to file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the Company and the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of
this 30th day of March, 2009.

Signature:  /s/ Michael Novelly
	        Michael Novelly





</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
